Medication info

Jincarosol Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›420mg / 100mLL-Leucine›660mg / 100mLL-Lysine Hydrochloride›400mg / 100mLL-Methionine›440mg / 100mLL-Phenylalanine›440mg / 100mLL-Threonine›200mg / 100mLL-Tryptophan›100mg / 100mLL-Valine›480mg / 100mLL-Arginine›400mg / 100mLL-Histidine›200mg / 100mLL-Proline›340mg / 100mLD-Sorbitol›5000mg / 100mL
Manufacturer / importer
SK Chemicals Co., Ltd.
Appearance
A colorless to pale yellow transparent liquid contained in a polypropylene aqueous injection vial.
Packaging
250mL/box
Approval status
Active

MFDS item code 198501017 · Notified 1985.01.09

Summary

Main use
Nutritional support through amino acid supplementation (e.g., for hypoproteinemia and malnutrition)
Who uses it
Adults · Children
Adult dosage
○ Adults: Administer a maximum daily dose of 1~1.5 g of total amino acids per kg of body weight by intravenous infusion. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred, and the general principle is to infuse at a rate of 80~130 drops per minute. However, the maximum daily dose is 100g of D-sorbitol.
Children's dosage
The dose and infusion rate should be adjusted for children, elderly patients, and patients with high protein requirements, such as burn patients.

Ingredients

Manufacturer
SK Chemicals Co., Ltd.

Efficacy & effects

Nutritional support through amino acid supplementation (e.g., for hypoproteinemia and malnutrition)

  • Hypoproteinemia
  • malnutrition.
View approved original text

The provision of amino acids is used to improve the nutritional status and recovery of patients in situations such as hypoproteinemia, malnutrition, and pre-and post-surgery.

Dosage and Administration

Adult dosage

○ Adults: Administer a maximum daily dose of 1~1.5 g of total amino acids per kg of body weight by intravenous infusion. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred, and the general principle is to infuse at a rate of 80~130 drops per minute. However, the maximum daily dose is 100g of D-sorbitol.

Children's dosage

The dose and infusion rate should be adjusted for children, elderly patients, and patients with high protein requirements, such as burn patients.

Precautions

This medication must be used under the guidance of a physician and should not be taken or stopped arbitrarily. It should not be administered to patients with serious liver dysfunction such as hepatic coma, severely impaired kidney function, or certain metabolic disorders. Use should also be avoided in patients with compromised heart function, lung issues, and those with very low or absent urine output. This medication contains certain ingredients that can cause allergic reactions or asthma attacks, so special caution is required for asthma patients or those with allergic dispositions. During administration, side effects such as rash, nausea, vomiting, discomfort in the chest, and rapid heartbeat may occur, and immediate communication with medical personnel is required if such symptoms appear. Rapid administration in large amounts may lead to acidosis, which is a condition of increased acidity in the blood, so it is important to control the rate and amount of administration. Electrolyte balance should be observed while using this medication, and interactions may occur when used with other drugs containing electrolytes. The safety of this medication has not been fully established in pregnant women, so it should be administered cautiously after consulting a physician. When administering to children or the elderly, adjustments to dosage and administration rate may be necessary due to different body functions, and frequent checks of condition through blood tests are recommended. Administration should be done slowly via intravenous infusion, and the injection solution should be warmed to body temperature before use. Aseptic conditions must be maintained when preparing and managing liquid preparations, and if there is discoloration or turbidity in the solution, it should not be used. When storing, it should be kept unopened, and if the packaging is damaged or if there are any abnormalities in the solution, it should not be used.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • tachycardia
  • hypertension
  • acidosis
  • heat sensation
  • vascular pain
Show 29 more
  • chill
  • fever
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • ureteral spasm
  • peripheral vascular dilatation
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes mellitus
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogen retention
  • hyperammonemia
  • loss of sensation
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent the entry of air or moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius. Care must be taken to avoid extremely high or low temperatures as they may reduce the medication's efficacy.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid contained in a polypropylene aqueous injection vial.

Package unit

250mL/box

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.